Skip to main content
Investigational uricase-based gout drug meets primary endpoints in phase 3 trials
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Investigational uricase-based gout drug meets primary endpoints in phase 3 trials
User login
Username
Password
Reset your password
Concept
Lead
score
Gout
1
1
Refractory
0
0.79
Washington
0
0.45
Washington DC
0
0.4
Immune Tolerance
0
0.16
Arthritis
0
0.11
Body Mass Index
0
0.11
Clinical Research
0
0.11
Europe
0
0.11
Georgia
0
0.11
Maryland
0
0.11
Prophylaxis
0
0.11
Quality of Life
0
0.11
Stomatitis
0
0.11
Texas
0
0.11
Tolerance
0
0.11
Xanthines
0
0.11
Anaphylaxis
0
0.07
Biologic Therapy
0
0.07
Dentistry and Oral Health
0
0.07
Healthcare and Medical Technology
0
0.07
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Edit Tags